To further elucidate the molecular mechanisms by which PDGFRA mediates lenvatinib resistance in HCC cells, we conducted additional experiments to assess the expression of downstream targets of the PDGF/PDGFRA signaling pathway, including mTOR, AKT, MEK, and ERK. This evidence concerns the gene AKT1 and hepatocellular carcinoma.